Benadryl
NDC 76413-353
Product Information
Benadryl is a OTC MONOGRAPH FINAL-approved product labeled by Central Texas Community Health Centers. This product is primarily utilized in pharmaceutical processing or compounding. It is supplied as a pink product. This product entry covers the primary NDC 76413-353 and its associated package configuration. This profile includes active and inactive ingredient UNII references and FDA labeling data.
Primary Identification
Labeler & Regulatory Data
Marketing Timeline
Product Characteristics
B;WL;25
Code Structure Chart
Product Details
What is NDC 76413-353?
What are the uses of this product?
Which are the associated UNII Codes?
The UNII codes for the active ingredients in this product are:
- DIPHENHYDRAMINE HYDROCHLORIDE (UNII: TC2D6JAD40)
- DIPHENHYDRAMINE (UNII: 8GTS82S83M) (Active Moiety)
Which are the Inactive Ingredients associated UNII Codes?
The inactive ingredients are all the component of a medicinal product OTHER than the active ingredient(s). The acronym "UNII" stands for “Unique Ingredient Identifier” and is used to identify each inactive ingredient present in a product. The UNII codes for the inactive ingredients in this product are:
- CARNAUBA WAX (UNII: R12CBM0EIZ)
- CROSCARMELLOSE SODIUM (UNII: M28OL1HH48)
- D&C RED NO. 27 (UNII: 2LRS185U6K)
- ALUMINUM OXIDE (UNII: LMI26O6933)
- DIBASIC CALCIUM PHOSPHATE DIHYDRATE (UNII: O7TSZ97GEP)
- HYPROMELLOSE, UNSPECIFIED (UNII: 3NXW29V3WO)
- MAGNESIUM STEARATE (UNII: 70097M6I30)
- MICROCRYSTALLINE CELLULOSE (UNII: OP1R32D61U)
- POLYETHYLENE GLYCOL, UNSPECIFIED (UNII: 3WJQ0SDW1A)
- POLYSORBATE 80 (UNII: 6OZP39ZG8H)
- TITANIUM DIOXIDE (UNII: 15FIX9V2JP)
What is the NDC to RxNorm Crosswalk for this product?
- RxCUI: 1049630 - diphenhydrAMINE HCl 25 MG Oral Tablet
- RxCUI: 1049630 - diphenhydramine hydrochloride 25 MG Oral Tablet
- RxCUI: 1049632 - Benadryl 25 MG Oral Tablet
- RxCUI: 1049632 - diphenhydramine hydrochloride 25 MG Oral Tablet [Benadryl]
- RxCUI: 1049632 - Benadryl Allergy Ultratab 25 MG Oral Tablet
* Please review the full disclaimer at the bottom of this page.